Key Laboratory of Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Medical College, Hangzhou Normal University, Hangzhou, 311100, China.
Biomark Med. 2020 Dec;14(17):1631-1639. doi: 10.2217/bmm-2020-0138.
To elucidate potential prognostic significance of NOTCH receptor and ligand expression in hepatocellular carcinoma. NOTCH receptors and ligands were divided into increased and decreased expression groups by X-tile program. The association between NOTCH receptors/ligands and prognosis was analyzed by Kaplan-Meier method and log-rank test. Gene set enrichment analysis was performed to explore NOTCH receptors/ligands-related pathways via gsea-3.0. DLL3 and DLL4 were independent prognostic factors for overall survival. Further studies showed that only DLL3 was significantly associated with tumor, node, metastasis stage. Gene set enrichment analysis analysis demonstrated that retinol metabolism, drug metabolism cytochrome P450 and tryptophan metabolism were significantly enriched in DLL3 expression phenotype. We demonstrate that DLL3 may be a prognostic biomarker in hepatocellular carcinoma.
为了阐明 NOTCH 受体和配体在肝细胞癌中的潜在预后意义。通过 X-tile 程序将 NOTCH 受体和配体分为表达增加和表达减少两组。通过 Kaplan-Meier 方法和对数秩检验分析 NOTCH 受体/配体与预后的关系。通过 gsea-3.0 进行基因集富集分析,以探索 NOTCH 受体/配体相关通路。DLL3 和 DLL4 是总生存的独立预后因素。进一步的研究表明,只有 DLL3 与肿瘤、淋巴结、转移分期显著相关。基因集富集分析分析表明,视黄醇代谢、药物代谢细胞色素 P450 和色氨酸代谢在 DLL3 表达表型中显著富集。我们证明 DLL3 可能是肝细胞癌的预后生物标志物。